Cargando…

Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes

Multidrug resistant (MDR) and extensively drug resistant tuberculosis (TB) are a threat to the TB control programs in developing countries, and the situation is worsened by the human immunodeficiency virus (HIV) pandemic. This study was performed to correlate treatment outcome with the resistance pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidyaraj, C.K., Chitra, A., Smita, S., Muthuraj, M., Govindarajan, S., Usharani, B., Anbazhagi, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Atlantis Press 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384569/ https://www.ncbi.nlm.nih.gov/pubmed/29110871 http://dx.doi.org/10.1016/j.jegh.2017.09.002

Ejemplares similares

Prevalence of mutations in genes associated with rifampicin and isoniazid resistance in Mycobacterium tuberculosis clinical isolates
por: Muthaiah, Muthuraj, et al.
Publicado: (2017)

Prevalence and factors associated with multidrug-resistant tuberculosis in South India
por: Shivekar, Smita S., et al.
Publicado: (2020)

Molecular Epidemiological Study of Pyrazinamide-Resistance in Clinical Isolates of Mycobacterium tuberculosis from South India
por: Muthaiah, Muthuraj, et al.
Publicado: (2010)

Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains
por: Song, Keum-Soo, et al.
Publicado: (2016)

Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda
por: Kigozi, Edgar, et al.
Publicado: (2018)

Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high Human Immunodeficiency Virus setting in Gambella regional state, southwest Ethiopia
por: Ejeta, Eyasu, et al.
Publicado: (2018)

Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022)

Human immunodeficiency virus coinfection with drug-resistant Mycobacterium tuberculosis
por: Zaharia-Kézdi, Iringó Erzsébet, et al.
Publicado: (2013)

In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
por: Bahraminia, F., et al.
Publicado: (2021)

Interpreting very low Mycobacterium tuberculosis detected on Xpert Mycobacterium tuberculosis/rifampicin
por: Ajbani, Kanchan, et al.
Publicado: (2019)

Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia
por: Arega, Balew, et al.
Publicado: (2019)

Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: A systematic review and meta-analysis
por: Rostamian, Mosayeb, et al.
Publicado: (2023)

Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
por: Araya, Shambel, et al.
Publicado: (2020)

Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India
por: Sethi, Sunil, et al.
Publicado: (2013)

Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China
por: Tong, Enyu, et al.
Publicado: (2023)

Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria
por: Ikuabe, Peter Ogie, et al.
Publicado: (2018)

Evaluation of phage assay for rapid phenotypic detection of rifampicin resistance in Mycobacterium tuberculosis
por: Yzquierdo, Sergio Luis, et al.
Publicado: (2006)

Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda
por: Ogwang, Sam, et al.
Publicado: (2009)

Correction: In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
por: Demitto, Fernanda de Oliveira, et al.
Publicado: (2015)

Resistance of Mycobacterium tuberculosis strains to Rifampicin: A systematic review and meta-analysis
por: Feyisa, Seifu Gizaw, et al.
Publicado: (2019)

Diagnostic performance of DNA microarray for detecting rifampicin and isoniazid resistance in Mycobacterium tuberculosis
por: Sun, Bingqi, et al.
Publicado: (2021)

Author Correction: Characterization of rifampicin-resistant Mycobacterium tuberculosis in Khyber Pakhtunkhwa, Pakistan
por: Khan, Anwar Sheed, et al.
Publicado: (2021)

Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China
por: Zhao, Bing, et al.
Publicado: (2022)

A Comparative Analysis of Microscopy, Culture, and the Xpert Mycobacterium tuberculosis/Rifampicin Assay in Diagnosing Pulmonary Tuberculosis in Human Immunodeficiency-Positive Individuals
por: Kumar, Manish, et al.
Publicado: (2023)

Prevalence of Mycobacterium tuberculosis infection and rifampicin resistance among presumptive tuberculosis cases visiting tuberculosis clinic of Adare General Hospital, Southern Ethiopia
por: Andarge, Degineh Belachew, et al.
Publicado: (2021)

Efficacy and role of Xpert(®) Mycobacterium tuberculosis/rifampicin assay in urinary tuberculosis
por: Samuel, Benedict Paul, et al.
Publicado: (2018)

Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014)

Prevalence of rifampicin resistant tuberculosis among pulmonary tuberculosis patients In Enugu, Nigeria
por: Ulasi, Amara, et al.
Publicado: (2022)

Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
por: Jaleta, Kefyalew N, et al.
Publicado: (2017)

Rifampicin resistant Mycobacterium tuberculosis and associated factors among presumptive pulmonary tuberculosis patients in Mogadishu, Somalia
por: Ali, Mohamed Muhumed, et al.
Publicado: (2023)

Detection of Rifampicin Resistance in Mycobacterium tuberculosis by Padlock Probes and Magnetic Nanobead-Based Readout
por: Engström, Anna, et al.
Publicado: (2013)

Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples
por: Lu, Wei, et al.
Publicado: (2012)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR
por: Sahebi, Leyla, et al.
Publicado: (2016)

Utility of the REBA MTB-rifa® assay for rapid detection of rifampicin resistant Mycobacterium Tuberculosis
por: Cho, Eunjin, et al.
Publicado: (2013)

Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India
por: Munir, Asma, et al.
Publicado: (2019)

Use of DNA microarray chips for the rapid detection of Mycobacterium tuberculosis resistance to rifampicin and isoniazid
por: Tang, Peijun, et al.
Publicado: (2017)

Frequency of genomic mutations mediating resistance of Mycobacterium tuberculosis isolates to rifampicin in Northern Morocco
por: Karimi, Hind, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f5g70b94jilmt30m1g1omme5b5